Login / Signup

Next-generation ALK inhibitors are highly active in ALK-positive large B-cell lymphoma.

Jacob D SoumeraiAllison RosenthalShannon K HarkinsJessica DuffyCarmen MeccaYingbing WangRavinder K GrewalAreej R El-JawahriHuiyun LiuCedric MenardAhmet DoganLei YangLisa M RimszaKurt BantilanHaley MartinMatthew M LeiSydney MohrAnna KurilovichOlga Mikhaylovna PlotnikovaEkaterina PostovalovaValentina NardiJeremy S AbramsonRoberto ChiarleAndrew D ZelenetzAbner Louissaint
Published in: Blood (2022)
Keyphrases
  • advanced non small cell lung cancer
  • diffuse large b cell lymphoma
  • epidermal growth factor receptor